Roche’s Genentech unit and Nvidia, the supercomputing hardware powerhouse, have signed a multi-year deal to speed up the pharma’s R&D work by using artificial intelligence, the companies said Tuesday.
The partnership is the latest step in Genentech’s growing AI ambitions, led by Aviv Regev, the biotech’s head of research and…
Click here to view original post
